Current status and future perspectives of immunotherapy in Latin America and Cuba

Abstract

Most Latin-American countries use subcutaneous immunotherapy (SCIT) extracts from the United States and Europe and sublingual immunotherapy (SLIT) from Europe, with the exception of Argentina, Brazil, Cuba and Mexico. The number of researches on immunotherapy (IT) in Latin America has increased extensively in the last years. Only few Latin American countries have their own guidelines on IT, and, in general, the economic resources for medical research on IT are still low in the area. A global approach for the future of IT in Latin America includes to improve standardization, quality control and the production of allergen products, to develop IT guidelines and clinical investigation by the highest number of countries, to improve the regulatory status for allergens products in the area, and to expand IT accessibility for low-income patients. In Cuba, the first registered allergen vaccines were developed and registered in 2006: a standardized (in biologic units) and freeze dried product for SCIT, with a sublingual version developed in 2009. As much as 23.000 IT treatments were applied in 2011, all provided to patients free of charge. In 2012, Cuban researchers developed an IT vaccine with adjuvant for subcutaneous route, which uses Neisseria meningitidis proteoliposome as an adjuvant, added to the purified Dermatophagoides siboney major allergens: Der s1 and Der s2. Since December 2012, this vaccine is in Phase I clinical trial, evaluating its safety, tolerability and immunogenicity in asthmatic patients sensitized to this allergen. Cuban perspectives on IT includes to work on new indications for IT, to investigate the preventive effect and cost-effectiveness for the current vaccines, to develop new products with mixed formulas of house dust mites for SLIT, to complete the phase I and II clinical study for dust mite plus adjuvant vaccine, to develop allergen vaccines for fungi allergy and to complete the Cuban guideline for allergen IT management.

A Cross Sectional Study on the 24 – Hour Variation of Fungal Pollution in the Atmosphere of Erbil City, Iraq

“…Nowadays, the relationship between total aeromycoflora and AF attracts more public awareness, and their relationship with respiratory disorders is clear enough. The predominant genera, such as Cladosporium, Aspergillus, and Alternaria, were discussed thoroughly in several studies [9,10]. Their daily and seasonal fluctuations showed different patterns, as did the concentration (CFUs/m3) [11,12].…”

Subcutaneous allergen immunotherapy for asthma: A randomized, double-blind, placebo-controlled study with a standardized Blomia tropicalis vaccine

“…2 Prevalence in Cuba is also high, ranging from 8.5% to 10% of adults and up to 17.8% of children. 3,4 In addition, the direct and indirect costs of asthma represent a major economic burden to the Cuban health care system and society. 5 House Dust Mite (HDM) allergens are strongly involved in the pathogenesis of allergic asthma.…”